// App-Quantinova.ai

TPS481 : A translational study to evaluate genomic markers and concordance with circulating-tumor DNA and circulating tumor cells to predict clinical outcomes in gastrointestinal and pancreatobiliary cancers: Valor trial.

Researchers

Presenter

  • Ayako Doi

Principal Investigators

  • Kumiko Umemoto

  • Tomoyo Oguri

  • Hiroyuki Takeda

  • Yoshiki Horie

  • Takashi Ogura

  • Takuro Mizukami

  • Naoki Izawa

  • Sungmok Jung

  • Byung Chul Kim

  • Yu Sunakawa

Medical Centers

  • Department of Pharmacy, St.Marianna University School of Medicine, Kawasaki, Japan

  • St.Marianna University School of Medcine, Kawasaki, Japan

  • Clinomics Inc., Suwon, South Korea

Locations

  • Japan

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • Circulating tumor cells

  • Circulating DNA

Drug/Treatment

  • Methadone hydrochloride

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • UMIN000036681

Sponsors

  • N/A

Result

  • N/A